Vilin Bio Med (NSE:VILINBIO) Total Assets : ₹309.44 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Total Assets?

Vilin Bio Med's Total Assets for the quarter that ended in Sep. 2023 was ₹309.44 Mil.

During the past 12 months, Vilin Bio Med's average Total Assets Growth Rate was 80.60% per year.

Total Assets is connected with ROA %. Vilin Bio Med's annualized ROA % for the quarter that ended in Sep. 2023 was 4.97%. Total Assets is also linked to Revenue through Asset Turnover. Vilin Bio Med's Asset Turnover for the quarter that ended in Sep. 2023 was 0.25.

Vilin Bio Med Total Assets Historical Data

The historical data trend for Vilin Bio Med's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Total Assets Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

Total Assets

140.06

138.91

135.58

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
Total Assets	140.06	138.91	135.58	-	309.44

Vilin Bio Med Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Vilin Bio Med's Total Assets for the fiscal year that ended in Mar. 2022 is calculated as

Total Assets	=	Total Equity (A: Mar. 2022 )	+	Total Liabilities (A: Mar. 2022 )
	=	73.962	+	61.621
	=	135.58

Vilin Bio Med's Total Assets for the quarter that ended in Sep. 2023 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2023 )	+	Total Liabilities (Q: Sep. 2023 )
	=	234.467	+	74.977
	=	309.44

Vilin Bio Med (NSE:VILINBIO) Total Assets Explanation

Total Assets is connected with ROA %.

Vilin Bio Med's annualized ROA % for the quarter that ended in Sep. 2023 is

ROA %	=	Net Income (Q: Sep. 2023 )	/	( (Total Assets (Q: Sep. 2022 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	15.382	/	( (0	+	309.444)	/ 1 )
	=	15.382	/	309.444
	=	4.97 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Vilin Bio Med's Asset Turnover for the quarter that ended in Sep. 2023 is

	Asset Turnover
=	Revenue (Q: Sep. 2023 )	/	( (Total Assets (Q: Sep. 2022 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
=	76.457	/	( (0	+	309.444)	/ 1 )
=	76.457	/	309.444
=	0.25

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Vilin Bio Med Total Assets Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines